- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05551078
Thrombophilia Screening After Severe IUGR
September 20, 2022 updated by: Central Hospital, Nancy, France
Thrombophilia Screening in Women After Severe IUGR
This retrospective study aims to assess the input of thrombophilia screening in pregnant women with severe intra-uterine growth restricted babies.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Anticipated)
100
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Nancy, France, 54000
- Recruiting
- Matthieu Dap
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Sampling Method
Non-Probability Sample
Study Population
- Women over 18 years old
- Pregnant women
- IUGR defined by an EFW <3rd centile
- IUGR before 25 GW
Description
Inclusion Criteria:
- Women over 18 years old
- Pregnant women
- IUGR defined by an EFW <3rd centile
- IUGR before 25 GW
Exclusion Criteria:
- none
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
pregnant women with severe IUGR
|
In the IUGR group systematic thrombophilia screening had already been performed.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Rate of positive's thrombophilia screening
Time Frame: 5 years
|
5 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
September 15, 2022
Primary Completion (ANTICIPATED)
October 1, 2022
Study Completion (ANTICIPATED)
January 1, 2023
Study Registration Dates
First Submitted
September 20, 2022
First Submitted That Met QC Criteria
September 20, 2022
First Posted (ACTUAL)
September 22, 2022
Study Record Updates
Last Update Posted (ACTUAL)
September 22, 2022
Last Update Submitted That Met QC Criteria
September 20, 2022
Last Verified
September 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2022PI102
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pregnancy Complications
-
The Cooper Health SystemRecruitingPregnancy,Neoplastic ComplicationsUnited States
-
Northwestern UniversityTerminatedPregnancy Related | Labor ComplicationUnited States
-
The George Washington University Biostatistics...Eunice Kennedy Shriver National Institute of Child Health and Human Development...Terminated
-
Jazz PharmaceuticalsRecruitingPregnancy | Pregnancy Complication | Maternal Complications | Birth Outcomes, AdverseUnited States
-
Oslo University HospitalRecruitingPregnancy Related | Labor Complication | Induced; BirthNorway
-
Washington University School of MedicineUniversity of MichiganRecruiting
-
Egas Moniz - Cooperativa de Ensino Superior, CRLCompleted
-
Thomas Jefferson UniversityCompleted
-
University Hospital Center of MartiniqueCompletedLabor Complication | CervixMartinique
-
PerspectumUniversity of Oxford; Fetal Medicine FoundationCompletedPregnancy Complications | Fetal Growth ComplicationsUnited Kingdom
Clinical Trials on thrombophilia screening
-
Sohag UniversityRecruiting
-
University of ZurichCompletedLivedoid VasculitisSwitzerland
-
Cardioangiologisches Centrum BethanienCompleted
-
McMaster UniversityCanadian Institutes of Health Research (CIHR)TerminatedVenous Thromboembolism | Fetal DeathAustralia, Canada
-
Royal Free Hospital NHS Foundation TrustUnknown
-
Vastra Gotaland RegionRecruiting
-
Centre Hospitalier Universitaire de NīmesTerminatedAntiphospholipid SyndromeFrance
-
University of FloridaPatient-Centered Outcomes Research InstituteEnrolling by invitation
-
Peking University People's HospitalSun Yat-sen University; Fudan University; Sun Yat-Sen Memorial Hospital of Sun... and other collaboratorsCompletedBreast Cancer | Bone MetastasesChina
-
National Institute of Allergy and Infectious Diseases...Ohio Department of Health, City of Cincinnati Board of HealthCompleted